Home
Scholarly Works
Theophylline-7β-d-Ribofuranoside (Theonosine), a...
Journal article

Theophylline-7β-d-Ribofuranoside (Theonosine), a New Theophylline Metabolite Generated in Human and Animal Lung Tissue

Abstract

While assessing the ability of mammalian lung tissue to metabolize theophylline, a new metabolite was isolated and characterized. The metabolite was produced by the microsomal fraction of lungs from several species, including rat, rabbit, dog, pig, sheep and human tissue. Metabolite production was blocked by boiling the microsomal tissue. This new metabolite, theophylline-7β-d-ribofuranoside (theonosine), was confirmed by several spectral methods and by comparison to an authentic synthetic compound. Tissue studies from rats, rabbits, dogs, and humans for cofactor involvement demonstrated an absolute requirement for NADP and enhanced metabolite production in the presence of magnesium ion. It remains to be demonstrated whether theonosine may contribute to the known pharmacological effects of theophylline.

Authors

Sitar DS; Bowen JM; He J; Tesoro A; Spino M

Journal

Pharmaceutics, Vol. 9, No. 3,

Publisher

MDPI

Publication Date

September 1, 2017

DOI

10.3390/pharmaceutics9030028

ISSN

1999-4923

Contact the Experts team